Nortriptyline for the treatment of depression in progressive supranuclear palsy.
Tamai
S
S
Almeida
O P
OP
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D015259:Dopamine Agents / Q000627:therapeutic use; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009661:Nortriptyline / Q000627:therapeutic use*; D012074:Remission Induction; D013494:Supranuclear Palsy, Progressive / Q000150:complications*
D018759:Adrenergic Uptake Inhibitors; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D015259:Dopamine Agents; D005473:Fluoxetine; D007980:Levodopa; D009661:Nortriptyline